U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

2023
446
Substance Class Protein
Created
by admin
on Tue Apr 01 18:02:26 GMT 2025
Edited
by admin
on Tue Apr 01 18:02:26 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED/CHIMERIC RAT
Sequence Type COMPLETE
Record UNII
P7186074QC
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
Rozanolixizumab
INN   WHO-DD  
USAN   INN  
Official Name English
Immunoglobulin G4, anti-(human FcRn receptor) (human-Rattus norvegicus monoclonal UCB 7665 heavy chain), disulfide with human-Rattus norvegicus monoclonal UCB 7665 light chain, dimer
Preferred Name English
Rozanolixizumab [WHO-DD]
Common Name English
UCB-7665
Code English
rozanolixizumab [INN]
Common Name English
ROZANOLIXIZUMAB [USAN]
Common Name English
ROZANOLIXIZUMAB [JAN]
Common Name English
UCB7665
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
NCI_THESAURUS C574
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
EU-Orphan Drug EU/3/18/2131
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
FDA ORPHAN DRUG 669918
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
FDA ORPHAN DRUG 636618
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
Code System Code Type Description
USAN
LM-43
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
SMS_ID
100000173495
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
INN
10213
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
FDA UNII
P7186074QC
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
CAS
1584645-37-3
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
DRUG BANK
DB14919
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
DAILYMED
P7186074QC
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
NCI_THESAURUS
C152270
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
From To
1_22 1_96
1_144 1_200
1_258 1_318
1_364 1_422
2_22 2_96
2_144 2_200
2_258 2_318
2_364 2_422
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
1_131 3_219
2_131 4_219
1_223 2_223
1_226 2_226
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_294
N 2_294
Related Record Type Details
Rozanolixizumab-NOLI
SUB_CONCEPT->SUBSTANCE
NEONATAL FC RECEPTOR
TARGET -> INHIBITOR
Related Record Type Details
Rozanolixizumab
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966